BIOLINQ
Live / Allowed — Notice of allowance issued (as of 27 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Jan 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97764181
- Mark type
- Stylized text
- Filed
- 23 Jan 2023
- Published for opposition
- 02 Dec 2025
- Attorney of record
- JOHN PAUL OLEKSIUK
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable software used with wearable sensors for monitoring blood glucose and managing diabetes; downloadable mobile application software used with wearable sensors for monitoring blood glucose and managing diabetes; none of the foregoing relating to incontinence or geriatric care
Owner
- Biolinq Incorporated, San Diego, CA, US
- Biolinq Incorporated, San Diego, CA, US
Prior registrations
Prosecution history
- 27 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Oct 2025 — EXPARTE APPEAL TERMINATED
- 27 Oct 2025 — EXPARTE APPEAL DISMISSED AS MOOT
- 11 Feb 2025 — EX PARTE APPEAL-INSTITUTED
- 11 Feb 2025 — EXPARTE APPEAL RECEIVED AT TTAB
- 06 Nov 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 06 Nov 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 14 Aug 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 14 Aug 2024 — FINAL REFUSAL E-MAILED
- 14 Aug 2024 — FINAL REFUSAL WRITTEN
- 27 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED